Shareholder alert: pomerantz law firm investigates claims on behalf of investors of regeneron pharmaceuticals, inc. - regn

New york , july 17, 2023 /prnewswire/ -- pomerantz llp is investigating claims on behalf of investors of regeneron pharmaceuticals, inc. ("regeneron" or the "company") (nasdaq: regn). such investors are advised to contact robert s.

REGN Ratings Summary

REGN Quant Ranking